ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma

Li, Ping; Liu, Yang; Liang, Yun; Bo, Jian; Gao, Sujun; Hu, Yongxian; Hu, Yu; Huang, He; Huang, Xiaojun; Jing, Hongmei; Ke, Xiaoyan; Li, Jianyong; Li, Yuhua; Liu, Qifa; Lu, Peihua; Mei, Heng; Niu, Ting; Song, Yongping; Song, Yuqin; Su, Liping; Tu, Sanfang; Wang, Jianxiang; Wu, Depei; Wang, Zhao; Xu, Kailin; Ying, Zhitao; Yang, Qingming; Zhang, Yajing; Shi, Fengxia; Zhang, Bin; Zhang, Huilai; Zhang, Xi; Zhao, Mingfeng; Zhao, Weili; Zhao, Xiangyu; Huang, Liang; Zhu, Jun; Qian, Wenbin*北京大学; 华中科技大学; 吉林大学; 南方医科大学; 上海交通大学; 四川大学; 浙江大学; 郑州大学; 苏州大学; 同济大学; 中国医学科学院; 中国医学科学院北京协和医院; 1; 5
Cancer Biology & Medicine2023-2-15DOI: 10.20892/j.issn.2095-3941.2022.0585
1被引26阅读
引用收藏
分享

摘要

Adoptive cellular immunotherapy with chimeric antigen receptor (CAR) T cells has emerged as a novel modality for treating relapsed and/or refractory B-cell non-Hodgkin lymphoma (B-NHL). With increasing approval of CAR T-cell products and advances in CAR T cell therapy, CAR T cells are expected to be used in a growing number of cases. However, CAR T-cell-associated toxicities can be severe or even fatal, thus compromising the survival benefit from this therapy. Standardizing and studying the clinical management of these toxicities are imperative. In contrast to other hematological malignancies, such as acute lymphoblastic leukemia and multiple myeloma, anti-CD19 CAR T-cell-associated toxicities in B-NHL have several distinctive features, most notably local cytokine-release syndrome (CRS). However, previously published guidelines have provided few specific recommendations for the grading and management of toxicities associated with CAR T-cell treatment for B-NHL. Consequently, we developed this consensus for the prevention, recognition, and management of these toxicities, on the basis of published literature regarding the management of anti-CD19 CAR T-cell-associated toxicities and the clinical experience of multiple Chinese institutions. This consensus refines a grading system and classification of CRS in B-NHL and corresponding measures for CRS management, and delineates comprehensive principles and exploratory recommendations for managing anti-CD19 CAR T-cell-associated toxicities in addition to CRS.

学科与关键词

关键词
CAR T-cell therapyB-cell non-Hodgkin lymphomatoxicitycytokine-release syndromeclinical management
相关
加载中…
  • CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
    Zhang, Xiaomin; Zhu, Lingling; Zhang, Hui; Chen, Shanshan; Xiao, Yang*Frontiers in Immunology, 2022, 13: 927153.被引 47
  • Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
    Xiao, Xinyi; Huang, Shengkang; Chen, Sifei; Wang, Yazhuo; Sun, Qihang; Xu, Xinjie*; Li, Yuhua*JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40(1): 367.被引 60
  • Chinese expert consensus on the management of chimeric antigen receptor T cell therapy-associated coagulopathy
    Mei, Heng*; Chen, Fangping; Han, Yue; Hou, Ming; Huang, He; Huang, Xiaojun; Li, Yuhua; Liang, Aibin; Liu, Qifa; Niu, Ting; Peng, Jun; Qian, Wenbin; Song, Yongping; Wang, Jianxiang; Wang, Ying; Wu, Depei; Xu, Kailin; Yang, Linhua; Yang, Renchi; Zhang, Lei; Zhang, Liansheng; Zhang, Xi; Zhang, Xiaohui; Zhao, Weili; Han, Weidong*; Hu, Yu*Chinese Medical Journal, 2022, 135(14): 1639-1641.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Biology & Medicine
发表日期
2023-02-15
卷期
第 20 卷, 第 2 期
页码
129-146
DOI
10.20892/j.issn.2095-3941.2022.0585
期刊收录
CAST-P
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81830002, 81830004, 82070168, 32070951]; National Key R&D Program of China [2020ZKZC04]; NCRCH; [2021YFA1100800]

作者

  • L

    Li, Ping (第一作者)

    tongji univ

  • L

    Liu, Yang

    chinese peoples liberat army gen hosp

查看全部 40 位作者收起作者
  • L

    Liang, Yun

    2 · zhejiang univ

  • B

    Bo, Jian

    chinese peoples liberat army gen hosp

  • G

    Gao, Sujun

    jilin univ

  • H

    Hu, Yongxian

  • H

    Hu, Yu

  • H

    Huang, He

    1 · zhejiang univ

  • H

    Huang, Xiaojun

    peking univ

  • J

    Jing, Hongmei

    peking univ

  • K

    Ke, Xiaoyan

    peking univ

  • L

    Li, Jianyong

    1 · chinese acad med sci · nanjing med univ · peking union med coll · peking univ canc hosp & inst · shanxi canc hosp · sichuan univ · southern med univ · zhengzhou univ

  • L

    Li, Yuhua

  • L

    Liu, Qifa

  • L

    Lu, Peihua

  • M

    Mei, Heng

    huazhong univ sci & technol

  • N

    Niu, Ting

  • S

    Song, Yongping

  • S

    Song, Yuqin

  • S

    Su, Liping

  • T

    Tu, Sanfang

  • W

    Wang, Jianxiang

    1 · 5 · capital med univ · chinese acad med sci · chinese peoples liberat army gen hosp · huazhong univ sci & technol · peking union med coll · shanghai jiao tong univ · shanghai ruijin hosp · soochow univ · tianjin first cent hosp · tianjin med univ canc inst & hosp · xinqiao hosp · xuzhou med univ

  • W

    Wu, Depei

  • W

    Wang, Zhao

  • X

    Xu, Kailin

  • Y

    Ying, Zhitao

  • Y

    Yang, Qingming

    chinese peoples liberat army gen hosp

  • Z

    Zhang, Yajing

    chinese peoples liberat army gen hosp

  • S

    Shi, Fengxia

    chinese peoples liberat army gen hosp

  • Z

    Zhang, Bin

  • Z

    Zhang, Huilai

  • Z

    Zhang, Xi

  • Z

    Zhao, Mingfeng

  • Z

    Zhao, Weili

  • Z

    Zhao, Xiangyu

    peking univ

  • H

    Huang, Liang

  • Z

    Zhu, Jun

  • Q

    Qian, Wenbin (通讯)

    2 · zhejiang univ

  • H

    Han, Weidong (通讯)

    chinese peoples liberat army gen hosp

  • L

    Liang, Aibin (通讯)

    tongji univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417